Exo Unveils Handheld Ultrasound Device

What You Should Know:

• Exo (pronounced “echo”), a medical imaging software and device company, today unveiled a category-redefining handheld ultrasound device, Exo Iris™, to put high-performance medical imaging into the hands—and pockets—of every caregiver.
• Built on Exo’s advanced silicon technology, Exo Iris delivers versatile imaging performance for point-of-care ultrasound (POCUS) at a fraction of the size and cost of cart-based systems. Exo Iris is the latest addition to Exo’s ecosystem, which combines imaging, workflow software, and artificial intelligence (AI) to enable POCUS adoption at a systems-wide scale to create new patient care pathways. Exo Iris gives caregivers—including physicians, nurses, EMTs, and clinicians in emergency, acute care, outpatient, and at-home settings—a window into the human body for immediate answers at the point of care.

Increasing Access to High Quality Medical Imaging at Low Costs

“Exo Iris represents a new era of ultrasound,” said Sandeep Akkaraju, CEO and Co-Founder of Exo. “It’s built to perform as easily as taking an image with a smartphone. For caregivers who’ve bemoaned out-of-touch medical technology, you’ve been heard. This device is meant for you and everyone in healthcare—it will save lives, improve patient care, and lower costs. A testament to the transformative power of great design, Exo Iris is the first of many innovations to come that will redefine the medical imaging space. We’re just getting started.”

Designed around the caregiver, Exo Iris blends a simple user experience with powerful, real-time AI to enable even novice users to get instant answers at their fingertips. The company’s patented SweepAI™ technology automatically acquires images with a sweep of the caregiver’s wrist, reducing operator dependence and bias to ensure consistent and accurate imaging. 

Exo Iris comes equipped with Exo’s Bladder AI solution to help caregivers determine bladder volume in seconds. Exo has a suite of additional AI solutions coming soon, including FDA 510k-pending advanced Cardiac and Lung AI suites that provide real-time guidance and answers for caregivers to quickly and accurately diagnose, triage, and monitor heart and pulmonary conditions.

Exo Iris is powered by Exo’s patented pMUT-based technology that blends the imaging excellence of piezoelectric crystals with silicon’s affordability. Exo’s silicon architecture allows for rapid imaging quality evolution and delivers real-time AI capabilities where every frame can be analyzed to guide the user to an immediate answer. The beauty of Exo Iris is that, when paired with this real-time AI, it doesn’t matter who the caregiver is: the same quantifiable answer is possible. 

With this industry-first technology, Exo Iris delivers unparalleled sensitivity for seeing deeper into the body or tracking fine structures, enabling caregivers to scan all major organs and guide IVs and line procedures. In addition, caregivers have access to novel features like ultra-wide field of view for imaging up to 150 degrees, allowing them to capture an entire liver or full-body fetus in one view. Hospitals can easily connect Exo Iris to existing healthcare IT systems for compliance and storage, whether it be their PACS or VNA. They can also store exams on Exo’s secure cloud environment.

 Additionally, Exo Iris can function without an internet connection, making it essential for caregivers in rural settings and in mobile response. Exo Iris comes equipped with Exo’s point-of-care ultrasound workflow solution, Exo Works™, to seamlessly document and review exams in seconds from anywhere. This combination blends an entire medical imaging ecosystem to perform flawlessly across hospitals, clinics, and at home, making communication across all spectrums of care possible. With Exo enabling system-wide adoption, health organizations finally have an answer for enterprise-level POCUS investment.

imaging
healthcare
health
medical
device
artificial intelligence
ai
smartphone
software
fda